Agenda
Friday, November 13, 2009 | |
|
|
7:30 am | Registration and Continental Breakfast |
8:00 | Welcome |
8:15 | Overview and Update on Federal Rules Regulating the Prescribing of Scheduled Medications |
9:30 | Special Workshop Session I |
| Challenges in Cancer Pain |
10:30 | Break |
10:45 | Workshop Sessions II |
|
|
Noon | Lunch |
1:15 pm | Palliative Care in the ICU |
2:15 | 6th Annual John Mendelsohn Award - 2009 Ceremony and Introduction of Keynote Speaker |
2:30 | 6th Annual John Mendelsohn Award for Outstanding Contributions in the Development of the Field of Palliative Care Presentation Advancing Palliative Care for Cancer Patients: Nationally and Internationally |
| Kathleen Foley, MD | |
3:30 | Break |
3:45 | The Art and Science of Compassion: Recent Advances in Neuroscience and their Implications for Palliative Medicine |
4:45 | Day 1 Concluding Remarks |
5:00 pm | Adjourn |
|
|
Saturday, November 14, 2009 | |
|
|
7:30 am | Registration and Continental Breakfast |
8:00 | Cancer Patients and Hope: Panel Discussion |
9:10 | Workshop Sessions III |
|
|
10:20 | Break |
10:35 | 2009 Lifetime Achievement Award Ceremony and Introduction of Keynote Speaker |
| M. Kay Swint, RN, MSN, CHPN | |
11:00 | The University of Texas M. D. Anderson Cancer Center Palliative & Hospice Care Lifetime Nursing Achievement Award PresentationThe Nature of Suffering and the Goals of Nursing |
Noon | Lunch |
1:00 pm | Workshop Sessions IV |
|
|
2:00 | Special Workshop Sessions V |
| Quality of Spiritual Care as an Aspect of Palliative Care |
3:00 | Break |
3:15 | How to Teach Communication Skills |
4:15 | Overview of Recent Research and Conclusion |
5:00 pm | Adjourn |
The University of Texas M. D. Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. M. D. Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.
Agendas are subject to change because we are always striving to improve the quality of your educational experience. M. D. Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness, scheduling conflicts, and so forth.
Photographing, audio taping and videotaping are prohibited

